Company news
Eve Health Group Limited (ASX:EVE) news
Every Eve Health Group Limited press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Quarterly Activities/Appendix 4C Cash Flow Report - Amended
August 6, 2026
Eve Initiates Pilot Clinical Study for Libbo ED Film
June 15, 2026
Appointment of Chief Executive Officer
April 27, 2026
Investor Presentation
March 25, 2026
Prospectus
March 20, 2026
EVE Placement Update
March 18, 2026
EVE Raises $0.9m to Advance Drug Reformulation Strategy
March 12, 2026
Trading Halt
March 10, 2026
EVE Advances Reformulated Drugs Targeting Global Markets
March 9, 2026
Appendix 4D and Half Year Report
February 27, 2026
Launch of Libbo and Activation of Men's Health Platform
February 9, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
January 30, 2026
EVE Completes Initial Production of Libbo
January 29, 2026
EVE Signs Telehealth Services Agreement with hubMed -Revised
November 19, 2025
EVE Signs Telehealth Services Agreement with hubMed
November 18, 2025
Medical Science Liaison Appointed
November 2, 2025
EVE Raises $1.1m to Accelerate Launches of Dyspro and Libbo
October 8, 2025
Dyspro Prescribed to First Patients
September 30, 2025
Eve Commences Distribution of Dyspro
September 21, 2025
Appointment of Dr Fiona Cousins to Scientific Advisory Board
September 14, 2025
Appendix 4E
August 29, 2025
Aust Regulatory Path Cleared for ED & Dysmenorrhea Products
July 20, 2025
EVE Submits First Commercial Purchase Order for Dyspro
July 6, 2025
Prescribing Agreement for ED and Dysmenorrhea Products
June 15, 2025
EVE Completes Nextract Acquisition
June 12, 2025
Results of Meeting
May 29, 2025
Notice of General Meeting/Proxy Form
April 29, 2025
Reinstatement to Quotation
April 14, 2025
EVE to Acquire Nextract, Expanding into $5.3B ED Market
April 14, 2025
Suspension from Quotation
April 4, 2025
Quarterly Activities/Appendix 5B Cash Flow Report
October 23, 2024
Preliminary Final Report
August 30, 2024
Sale of Robyndale Property (Amended)
August 30, 2024
Sale of Robyndale Property
August 30, 2024
Sale of Jendale Property
April 29, 2024
Farm Sale and Funding Update
January 31, 2024
Appendix 4E - Results for Announcement to the Market
August 30, 2023
Appendix 4C - December Quarter 2022
January 31, 2023
Appendix 4C - September Quarter 2022
October 25, 2022
Appendix 4E and Preliminary Final Report
August 31, 2022
Appendix 4C - June Quarter 2022
July 27, 2022
Rights Issue Offer Document
June 5, 2022
Non-Renounceable Rights Offer
May 29, 2022
Eve Health : Notification regarding unquoted securities - EVE
May 2, 2022
Appendix 4C - March Quarter 2022
April 29, 2022
Eve Health : Update - Proposed issue of securities - EVE
April 20, 2022
Eve Health : Application for quotation of securities - EVE
February 27, 2022
$1.4m Share Placement
February 21, 2022
Appendix 4C - December Quarter 2021
January 31, 2022
Meluka Australia - Half Year Update
January 19, 2022